Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Medivir Aktiebolag
AB
Active
Org 5562384361
Lunastigen 5, 141 44
Huddinge
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 1987
10 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Medivir Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
34M
68M
102M
136M
26M
2021
4M
2022
8M
2023
3M
2024
118M
2025
EBITDA
SEK millions
0M
14M
28M
41M
55M
-62M
2021
-88M
2022
-92M
2023
-128M
2024
48M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
25 538
4 408
7 633
3 484
117 752
Staff expenses
—
—
—
—
—
EBITDA
−62 134
−87 559
−91 771
−127 857
47 680
Depreciation & amort.
−330
−204
−137
−127
−29 912
EBIT
−62 464
−87 763
−91 908
−127 984
17 768
Net financials
7 150
−665
3 531
4 804
−1 168
Profit before tax
−55 314
−87 938
−88 377
−123 180
16 600
Tax
−0
−0
−0
−0
−0
Net profit
−55 314
−87 938
−88 377
−123 180
16 600
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
322 204
219 905
276 595
163 876
300 347
Equity
280 124
192 186
218 331
116 060
266 758
Long-term debt
0
0
0
0
0
Short-term debt
42 080
27 719
58 264
47 817
31 203
Total debt
42 080
27 719
58 264
47 817
31 203
Financial ratios
5-year trend
EBITDA margin
40.5%
This company
15.8%
Market median
+156% vs market
2021
2025
Equity ratio
88.8%
This company
38.2%
Market median
+132% vs market
2021
2025
Return on equity
6.2%
This company
18.4%
Market median
-66% vs market
2021
2025
Net profit margin
14.1%
This company
8.1%
Market median
+74% vs market
2021
2025
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
2021
2025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Medivir Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
